Manufactures health, hygiene, and nutrition products. Offers a diverse range of brands including Dettol, Durex, and Gaviscon. Now — the numbers.
This is an established company with proven profits.
No real growth (2% a year). Red columns mark years that ended in a loss.
The gap is $8.8B. In times of high interest rates, a gap like that can squeeze a company.
The market pays 10× for every dollar of annual profit — cheap, which is either an opportunity or a warning.
No analyst target is on record for this company.
The stock trades 26% below its peak. The market has trimmed its expectations for the company.
The net profit margin is 22% — still a thick cushion, though costs have been eating into it lately.
Over the last 4 years, sales grew only 2% a year on average. At this size, speeding back up is not easy.
Since the drop from its peak, buyer appetite hasn’t come back.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the revenue breakdown.